Improvement and extension of anti-EGFR targeting in breast cancer therapy by integration with the Avidin-Nucleic-Acid-Nano-Assemblies

scientific article published in Nature Communications

Improvement and extension of anti-EGFR targeting in breast cancer therapy by integration with the Avidin-Nucleic-Acid-Nano-Assemblies is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2018NatCo...9.4070R
P356DOI10.1038/S41467-018-06602-6
P932PMC publication ID6172284
P698PubMed publication ID30287819

P50authorRonen AlonQ56931491
Margherita MorpurgoQ56998938
Roberto RoncaQ58660977
Giampietro ViolaQ66360924
Elena PorcùQ84112093
Fatlum RrugaQ92046448
P2093author name stringGiuseppe Basso
Elisabetta Casarin
Nicola Realdon
Federica Maccarinelli
Francesco Roncato
P2860cites workHallmarks of Cancer: The Next GenerationQ22252312
Three-dimensional structures of avidin and the avidin-biotin complexQ24562803
Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysQ25939005
Antibody drug conjugates: design and selection of linker, payload and conjugation chemistryQ28544658
Clathrin-independent endocytosis of ubiquitinated cargosQ33864329
Methyl 4-mercaptobutyrimidate as a cleavable crosslinking reagent and its application to the Escherichia coli 30S ribosomeQ34213591
Detection of a fluorescent-labeled avidin-nucleic acid nanoassembly by confocal laser endomicroscopy in the microvasculature of chronically inflamed intestinal mucosaQ34960433
Antibody-drug conjugates: linking cytotoxic payloads to monoclonal antibodies.Q35004254
Activation of KRAS promotes the mesenchymal features of basal-type breast cancerQ35040663
Liposome-based approaches to overcome anticancer drug resistanceQ35595419
A New ELISA Using the ANANAS Technology Showing High Sensitivity to diagnose the Bovine Rhinotracheitis from Individual Sera to Pooled MilkQ35892892
Doxorubicin-poly (ethylene glycol)-alendronate self-assembled micelles for targeted therapy of bone metastatic cancerQ36106734
TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancerQ36145430
Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancer.Q36832116
A Micelle Self-Assembled from Doxorubicin-Arabinoxylan Conjugates with pH-Cleavable Bond for Synergistic Antitumor TherapyQ37608021
Antibody-drug conjugates: current status and future directionsQ38163255
Enhancement of tumor uptake and therapeutic efficacy of EGFR-targeted antibody cetuximab and antibody-drug conjugates by cholesterol sequestrationQ38998238
The principles and applications of avidin-based nanoparticles in drug delivery and diagnosisQ39014347
Impact of epidermal growth factor receptor (EGFR) cell surface expression levels on effector mechanisms of EGFR antibodiesQ39253031
In vivo fate of avidin-nucleic acid nanoassemblies as multifunctional diagnostic tools.Q39297207
Immunoliposomal delivery of doxorubicin can overcome multidrug resistance mechanisms in EGFR-overexpressing tumor cells.Q39361715
Targeting tumor-associated endothelial cells: anti-VEGFR2 immunoliposomes mediate tumor vessel disruption and inhibit tumor growthQ39446636
DNMT3a plays a role in switches between doxorubicin-induced senescence and apoptosis of colorectal cancer cellsQ39703300
Correlation of the acid-sensitivity of polyethylene glycol daunorubicin conjugates with their in vitro antiproliferative activityQ40302861
Anti-CD74 antibody-doxorubicin conjugate, IMMU-110, in a human multiple myeloma xenograft and in monkeysQ40395390
Programmable co-delivery of the immune checkpoint inhibitor NLG919 and chemotherapeutic doxorubicin via a redox-responsive immunostimulatory polymeric prodrug carrierQ41078784
Therapeutic Efficacy of the Novel Stimuli-Sensitive Nano-Ferritins Containing Doxorubicin in a Head and Neck Cancer Model.Q41183225
Optimized avidin nucleic acid nanoassemblies by a tailored PEGylation strategy and their application as molecular amplifiers in detection.Q43043093
New hydrazone derivatives of adriamycin and their immunoconjugates--a correlation between acid stability and cytotoxicityQ43863877
Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells.Q44480735
DNA condensation by high-affinity interaction with avidin.Q45073809
Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study.Q50896680
Antibody–Drug Conjugates for Tumor Targeting—Novel Conjugation Chemistries and the Promise of non-IgG Binding ProteinsQ57839848
Preparation and some properties of maleimido acids and maleoyl derivatives of peptidesQ67248802
A method for the estimation of polyethylene glycol in plasma protein fractionsQ71387757
(6-Maleimidocaproyl)hydrazone of doxorubicin--a new derivative for the preparation of immunoconjugates of doxorubicinQ71609322
Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugatesQ72822953
A SPECTROPHOTOMETRIC ASSAY FOR AVIDIN AND BIOTIN BASED ON BINDING OF DYES BY AVIDINQ78535145
Characterization of multifunctional nanosystems based on the avidin-nucleic acid interaction as signal enhancers in immuno-detectionQ83636317
Redox-responsive mesoporous selenium delivery of doxorubicin targets MCF-7 cells and synergistically enhances its anti-tumor activityQ89428061
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P4510describes a project that usesImageJQ1659584
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectnanotechnologyQ11468
P304page(s)4070
P577publication date2018-10-04
P1433published inNature CommunicationsQ573880
P1476titleImprovement and extension of anti-EGFR targeting in breast cancer therapy by integration with the Avidin-Nucleic-Acid-Nano-Assemblies
P478volume9

Reverse relations

cites work (P2860)
Q91891550Active Targeting Strategies Using Biological Ligands for Nanoparticle Drug Delivery Systems
Q99579060Biointerface engineering nanoplatforms for cancer-targeted drug delivery
Q64944222Cryptotanshinone Suppresses Non-Small Cell Lung Cancer via microRNA-146a-5p/EGFR Axis.
Q64945320Nanoparticle Activation Methods in Cancer Treatment.
Q94562089Selective delivery of T22-PE24-H6 to CXCR4+ diffuse large B-cell lymphoma cells leads to wide therapeutic index in a disseminated mouse model

Search more.